Drugs and Devices

FDA approves extended-release, single-entity hydrocodone product

On Oct. 25, the U.S. Food and Drug Administration (FDA) approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough to require daily, around-the-clock, long-term treatment and for which alternative treatment options are inadequate.
Read more .


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares